Stock listing
Marker Therapeutics, Inc.
Selected listing: GX1 · GETTEX · EUR · DE
Marker Therapeutics, Inc. (gettex:GX1), Health Technology. Latest release Mar 18, 2026: Marker Therapeutics Reports Year-End 2025 Corporate and Financial…
- Ticker
- gettex:GX1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc. (MRKR) is a public company based in the United States, focused on developing innovative cell therapies for cancer treatment. Marker Therapeutics aims to address unmet medical needs in oncology through its unique approach to immunotherapy.
Latest news from Marker Therapeutics, Inc.
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
March 17, 2026
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
January 26, 2026
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
January 5, 2026
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 14, 2025
Events
Replays
Marker Therapeutics, Inc. (MRKR) Q2 2022 Earnings Call
Wed, Feb 16, 2022 · 05:00 PM ET
Watch
Research Marker Therapeutics, Inc.
Marker Therapeutics, Inc. company profile
View the public company page for Marker Therapeutics, Inc. on 6ix.
Marker Therapeutics, Inc. news
Read company news and market updates connected to Marker Therapeutics, Inc..
Marker Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Marker Therapeutics, Inc..
Alternate listings
MRKR:NASDAQ
US · USD
Alternate listing for Marker Therapeutics, Inc.; the primary context on this page is GX1:GETTEX.
MRKR:BOATS
US · USD
Alternate listing for Marker Therapeutics, Inc.; the primary context on this page is GX1:GETTEX.
GX1:FWB
DE · EUR
Alternate listing for Marker Therapeutics, Inc.; the primary context on this page is GX1:GETTEX.
GX1:MUN
DE · EUR
Alternate listing for Marker Therapeutics, Inc.; the primary context on this page is GX1:GETTEX.